These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34837475)

  • 1. Statins: A Panacea to Reduce Mortality in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma?
    Shawcross DL; Suddle A
    Liver Transpl; 2022 Mar; 28(3):357-358. PubMed ID: 34837475
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Lee HL; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK; Choi HJ; Na GH; You YK; Park IY; Kim DG
    Liver Transpl; 2022 Mar; 28(3):397-406. PubMed ID: 34374192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma and Statins.
    Alipour Talesh G; Trézéguet V; Merched A
    Biochemistry; 2020 Sep; 59(37):3393-3400. PubMed ID: 32865979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.
    Lee O; Rhu J; Choi GS; Kim JM; Kim K; Joh JW
    Ann Transplant; 2022 Apr; 27():e935604. PubMed ID: 35379768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is There a Role for Statins in Palliative Care for Patients Suffering from Hepatocellular Carcinoma?
    Björkhem-Bergman L
    J Palliat Care; 2015; 31(3):172-6. PubMed ID: 26514023
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and risk reduction in hepatocellular carcinoma: fact or fiction?
    Singh PP; Singh S
    J Clin Oncol; 2012 Jul; 30(20):2569-70; author reply 2570-2571. PubMed ID: 22689810
    [No Abstract]   [Full Text] [Related]  

  • 7. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
    Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
    BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence.
    Siegel AB; El-Serag HB
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):493-5. PubMed ID: 23984995
    [No Abstract]   [Full Text] [Related]  

  • 9. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
    Wei J; Lvy JH; Sun XJ; Wu XR
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
    Cho Y; Kim MS; Nam CM; Kang ES
    Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Huang R; Wang J; Wu W; Yan X; Wu C
    Hepatology; 2020 Jun; 71(6):2173-2174. PubMed ID: 31858599
    [No Abstract]   [Full Text] [Related]  

  • 12. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
    Carrat F
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhosis as new indication for statins.
    Bosch J; Gracia-Sancho J; Abraldes JG
    Gut; 2020 May; 69(5):953-962. PubMed ID: 32139553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Abraldes JG; Burak KW
    Hepatology; 2016 Jul; 64(1):13-5. PubMed ID: 26946464
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins, diabetes, obesity, nonalcoholic fatty liver disease, and hepatocellular carcinoma.
    Han J; Yan WT; Quan B; Wang MD; Yang T
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):202. PubMed ID: 30473472
    [No Abstract]   [Full Text] [Related]  

  • 16. Pleiotropic effects of statins in the diseases of the liver.
    Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
    World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.
    Kim G; Kang ES
    Semin Liver Dis; 2019 May; 39(2):141-152. PubMed ID: 30912095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
    Goh MJ; Sinn DH
    Clin Mol Hepatol; 2022 Jul; 28(3):380-395. PubMed ID: 35021597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma.
    Wang Y; Wang W; Wang M; Shi J; Jia X; Dang S
    Can J Gastroenterol Hepatol; 2022; 2022():5389044. PubMed ID: 35356132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.